Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03484065 · ClinicalTrials.gov registry record
Quality of Life in Patients With Congenital Afibrinogenemia
A clinical trial, sponsored by University Hospital, Geneva.
- Completed
- Registry status
- 250
- Enrollment target
NCT03484065: Completed study, sponsored by University Hospital, Geneva.
NCT03484065 is a clinical trial that has completed, run by University Hospital, Geneva. The registered enrollment target is 250 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03484065 has completed, sponsored by University Hospital, Geneva.
- COMPLETED
- Registry status
- 250 participants
- Enrollment target
Study Summary
The aim of this observational study is to evaluate the quality of life in patients with congenital afibrinogenemia using the Haemo-QoL SF for kids and the Haem-A-QoL for adult patients.
Primary Outcome
The quality of life questionnaire includes item assessing: * Physical health * Feeling * View * Family * Friends * Others * Sport and school * Treatment * Perceived support * Dealing * Future * Relationship
Interventions
- OTHER Questionnaire quality of life
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2016-06 |
| Est. Completion | 2020-06 |
What the finished NCT03484065 record still lists
NCT03484065 is an observational study that tracks outcomes without assigning an intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Questionnaire quality of life is the first listed.
NCT03484065 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03484065 about?
NCT03484065 is a clinical study titled "Quality of Life in Patients With Congenital Afibrinogenemia". The aim of this observational study is to evaluate the quality of life in patients with congenital afibrinogenemia using the Haemo-QoL SF for kids and the Haem-A-QoL for adult patients.
What is the current status of trial NCT03484065?
This trial is currently completed. The enrollment target is 250 participants. The study started on 2016-06. Estimated completion is 2020-06.
What interventions are being tested in trial NCT03484065?
The interventions under investigation include: Questionnaire quality of life (OTHER).
Who is sponsoring clinical trial NCT03484065?
This trial is sponsored by University Hospital, Geneva, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00483249 · 250 participants · NA
Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
- NCT00777712 · 250 participants
Mechanisms Underlying Impaired Diabetic Wound Healing
- NCT01451502 · 250 participants · NA
Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units
- NCT01771718 · 250 participants
Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia